Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: Possibilities for combination therapy

N. Banu, A. Buda, S. Chell, D. Elder, M. Moorghen, C. Paraskeva, D. Qualtrough, M. Pignatelli

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)

Fingerprint Dive into the research topics of 'Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: Possibilities for combination therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences